Hong Kong · Delayed Price · Currency is HKD Sino Biopharmaceutical Statistics
Total Valuation
HKG:1177 has a market cap or net worth of HKD 99.65 billion. The enterprise value is 103.42 billion.
| Market Cap | 99.65B |
| Enterprise Value | 103.42B |
Important Dates
The last earnings date was Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | Sep 1, 2026 |
Share Statistics
HKG:1177 has 17.81 billion shares outstanding. The number of shares has decreased by -0.19% in one year.
| Current Share Class | 17.81B |
| Shares Outstanding | 17.81B |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 51.05% |
| Owned by Institutions (%) | 21.73% |
| Float | 8.72B |
Valuation Ratios
The trailing PE ratio is 36.64 and the forward PE ratio is 18.26. HKG:1177's PEG ratio is 0.73.
| PE Ratio | 36.64 |
| Forward PE | 18.26 |
| PS Ratio | 2.56 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.73 |
Enterprise Valuation
| EV / Earnings | 37.49 |
| EV / Sales | 2.66 |
| EV / EBITDA | 8.75 |
| EV / EBIT | 9.61 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.63 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.65 |
| Debt / FCF | n/a |
| Interest Coverage | 29.25 |
Financial Efficiency
Return on equity (ROE) is 14.07% and return on invested capital (ROIC) is 20.62%.
| Return on Equity (ROE) | 14.07% |
| Return on Assets (ROA) | 7.51% |
| Return on Invested Capital (ROIC) | 20.62% |
| Return on Capital Employed (ROCE) | 16.90% |
| Weighted Average Cost of Capital (WACC) | 6.64% |
| Revenue Per Employee | 1.70M |
| Profits Per Employee | 120,783 |
| Employee Count | 21,435 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.91 |
Taxes
In the past 12 months, HKG:1177 has paid 2.13 billion in taxes.
| Income Tax | 2.13B |
| Effective Tax Rate | 22.17% |
Stock Price Statistics
The stock price has decreased by -25.00% in the last 52 weeks. The beta is 0.62, so HKG:1177's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -25.00% |
| 50-Day Moving Average | 4.90 |
| 200-Day Moving Average | 5.89 |
| Relative Strength Index (RSI) | 68.66 |
| Average Volume (20 Days) | 81,046,605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1177 had revenue of HKD 38.91 billion and earned 2.76 billion in profits. Earnings per share was 0.15.
| Revenue | 38.91B |
| Gross Profit | 32.07B |
| Operating Income | 10.96B |
| Pretax Income | 9.60B |
| Net Income | 2.76B |
| EBITDA | 12.02B |
| EBIT | 10.96B |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 31.84 billion in cash and 19.82 billion in debt, with a net cash position of 12.01 billion or 0.67 per share.
| Cash & Cash Equivalents | 31.84B |
| Total Debt | 19.82B |
| Net Cash | 12.01B |
| Net Cash Per Share | 0.67 |
| Equity (Book Value) | 53.39B |
| Book Value Per Share | 2.11 |
| Working Capital | 19.64B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.07B |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 82.43%, with operating and profit margins of 28.17% and 7.09%.
| Gross Margin | 82.43% |
| Operating Margin | 28.17% |
| Pretax Margin | 24.67% |
| Profit Margin | 7.09% |
| EBITDA Margin | 30.89% |
| EBIT Margin | 28.17% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 2.50%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 2.50% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 78.59% |
| Buyback Yield | 0.19% |
| Shareholder Yield | 3.11% |
| Earnings Yield | 2.77% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:1177 is 8.39, which is 47.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 8.39 |
| Price Target Difference | 47.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 10.61% |
| EPS Growth Forecast (3Y) | 3.03% |
Stock Splits
The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |